News Daily News No Clear Risk of Dementia After TIA: Framingham Heart Study L.A. McKeown July 10, 2025
News Daily News FDA Approves Triple Therapy Polypill for High Blood Pressure Michael O'Riordan June 10, 2025
News Conference News EuroPCR 2025 ‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI Michael O'Riordan May 29, 2025
News Daily News Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN Yael L. Maxwell April 29, 2025
News Daily News FDA Drops REMS Requirement for Antihypertensive Aprocitentan Michael O'Riordan April 09, 2025
News Daily News ‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials Michael O'Riordan February 20, 2025
News Conference News ISC 2025 Propranolol Linked to Stroke Protection in Women With Migraine L.A. McKeown February 06, 2025
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Daily News Female-Specific Factors Don’t Enhance Common Risk Calculators Caitlin E. Cox December 10, 2024
News Daily News Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis Todd Neale November 28, 2024
News Conference News AHA 2024 Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN Caitlin E. Cox November 22, 2024
News Conference News AHA 2024 Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD Yael L. Maxwell November 16, 2024
News Conference News AHA 2024 One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024 Shelley Wood November 14, 2024
Presentation TCT 2024 Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial Presenter: David Kandzari October 28, 2024
News Daily News Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction Todd Neale October 15, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024